Contract HHSO100201700020C
Regeneron Pharmaceuticals Inc · Department Of Health And Human Services · August 8, 2025
Regeneron Pharmaceuticals Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 8, 2025 for $279.61 million (current value) of work in research and development in biotechnology. Performance is in Tarrytown, NY. It was awarded under full and open competition. It uses cost sharing contract pricing. If all options are exercised, the contract could reach $360.38 million.
Contract details
- PIID
- HHSO100201700020C
- Award type
- Definitive Contract
- Pricing
- Cost Sharing
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Tarrytown, NY
- First action
- August 8, 2025
Description
EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING:: DESCOPE EXISTING WORK AND REMOVE UNUSED FUNDS AS DUE TO PROGRAMMATIC POLICY REVISIONS.
Modification timeline
-
August 8, 2025Mod P00016 · Other Administrative Action$279.61M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Transnetyx, Inc | Department Of Health And Human Services | June 25, 2026 | $18.3K |
| Deloitte Consulting Llp | Department Of Health And Human Services | June 18, 2026 | $50.0K |
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201700020C?
Contract HHSO100201700020C is a federal contract awarded to Regeneron Pharmaceuticals Inc by Department Of Health And Human Services on August 8, 2025 for $279.61 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.
Who won contract HHSO100201700020C?
Regeneron Pharmaceuticals Inc won contract HHSO100201700020C from Department Of Health And Human Services.
How much is contract HHSO100201700020C worth?
Contract HHSO100201700020C has obligated $0 to date but carries a potential ceiling of $360.38 million if fully funded and all options are exercised.